Intra-Cellular Therapies, Inc.
NASDAQ:ITCI
86.17 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | ||||||||||||
Current Assets: | ||||||||||||
Cash & Cash Equivalents
| 147.767 | 148.615 | 92.365 | 60.046 | 107.637 | 54.948 | 37.79 | 48.642 | 47.159 | 61.325 | 35.151 | 19.146 |
Short Term Investments
| 350.174 | 443.29 | 319.968 | 597.402 | 116.373 | 292.583 | 426.541 | 335.458 | 428.041 | 68.321 | 2 | 3.5 |
Cash and Short Term Investments
| 497.941 | 591.905 | 412.333 | 657.448 | 224.01 | 347.531 | 464.331 | 384.101 | 475.2 | 129.646 | 37.151 | 19.146 |
Net Receivables
| 114.018 | 75.189 | 20.156 | 10.765 | 0 | 0 | 0 | 0.094 | 0.031 | 0.052 | 0.336 | 0.3 |
Inventory
| 11.647 | 23.92 | 7.948 | 7.056 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Assets
| 42.443 | 45.193 | 26.843 | 15.635 | 6.314 | 7.908 | 4.884 | 4.005 | 8.025 | 1.289 | 0.762 | 0.189 |
Total Current Assets
| 667.799 | 737.957 | 467.281 | 690.904 | 230.324 | 355.439 | 469.215 | 388.2 | 483.256 | 130.986 | 38.249 | 19.635 |
Non-Current Assets: | ||||||||||||
Property, Plant & Equipment, Net
| 14.582 | 16.737 | 22.555 | 26.323 | 20.512 | 1.16 | 1.137 | 0.628 | 0.776 | 0.055 | 0.068 | 0.058 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Assets
| 0 | 0 | 0 | 0 | 0.265 | 0.529 | 1.058 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 45.914 | 0.086 | 0.086 | 0.086 | 0.086 | 0.079 | 0.076 | 0.076 | 0.072 | 0.071 | 0.132 | 0.131 |
Total Non-Current Assets
| 60.496 | 16.823 | 22.641 | 26.409 | 20.863 | 1.768 | 2.271 | 0.703 | 0.847 | 0.125 | 0.2 | 0.189 |
Total Assets
| 728.295 | 754.78 | 489.922 | 717.314 | 251.186 | 357.206 | 471.487 | 388.903 | 484.104 | 131.112 | 38.449 | 19.824 |
Liabilities & Equity: | ||||||||||||
Current Liabilities: | ||||||||||||
Account Payables
| 11.452 | 10.395 | 8.691 | 5.502 | 7.425 | 13.961 | 6.174 | 3.755 | 1.633 | 2.053 | 3.395 | 0.042 |
Short Term Debt
| 3.612 | 4.567 | 6.732 | 5.542 | 3.187 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.667 |
Other Current Liabilities
| 108.481 | 68.274 | 37.933 | 25.81 | 25.612 | 22.338 | 8.036 | 6.778 | 4.631 | 8.504 | 3.439 | 1.131 |
Total Current Liabilities
| 123.545 | 83.236 | 53.356 | 36.853 | 36.224 | 36.299 | 14.21 | 10.532 | 6.264 | 10.557 | 6.834 | 2.84 |
Non-Current Liabilities: | ||||||||||||
Long Term Debt
| 13.326 | 15.474 | 18.675 | 23.6 | 19.955 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | 0 | 3.192 | 2.84 | 2.869 | 1.597 | 2.053 | 3.395 | 1.708 |
Total Non-Current Liabilities
| 13.326 | 15.474 | 18.675 | 23.6 | 19.955 | 3.192 | 2.84 | 2.869 | 1.597 | 2.053 | 3.395 | 1.708 |
Total Liabilities
| 136.871 | 98.71 | 72.031 | 60.454 | 56.179 | 39.492 | 17.05 | 13.401 | 7.861 | 10.557 | 6.834 | 2.84 |
Equity: | ||||||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 0.01 | 0.009 | 0.008 | 0.008 | 0.006 | 0.005 | 0.005 | 0.004 | 0.004 | 0.003 | 0.002 | 0.001 |
Retained Earnings
| -1,617.16 | -1,477.486 | -1,221.23 | -937.104 | -710.098 | -562.376 | -407.249 | -309.475 | -193.049 | -88.256 | -57.564 | -30.696 |
Accumulated Other Comprehensive Income/Loss
| 0.104 | -4.19 | -0.364 | 0.481 | 0.128 | -0.668 | -0.799 | -0.317 | -0.59 | -0.105 | 0 | -3.22 |
Other Total Stockholders Equity
| 2,208.47 | 2,137.737 | 1,639.476 | 1,593.476 | 904.972 | 880.753 | 862.48 | 685.291 | 669.878 | 208.912 | 89.178 | 50.899 |
Total Shareholders Equity
| 591.424 | 656.07 | 417.891 | 656.86 | 195.007 | 317.715 | 454.437 | 375.503 | 476.243 | 120.555 | 31.615 | 16.984 |
Total Equity
| 591.424 | 656.07 | 417.891 | 656.86 | 195.007 | 317.715 | 454.437 | 375.503 | 476.243 | 120.555 | 31.615 | 16.984 |
Total Liabilities & Shareholders Equity
| 728.295 | 754.78 | 489.922 | 717.314 | 251.186 | 357.206 | 471.487 | 388.903 | 484.104 | 131.112 | 38.449 | 19.824 |